Nephros Inc (NEPH) Stock Price, Quote & News

Company Profile

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilitie...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 201 343 5202

Website: www.nephros.com

Address:

380 Lackawanna Place, South Orange, United States

MatthLewis Dec. 1 at 6:50 PM

$NEPH Being in both Russell 2000 and 3000 is a huge differentiator for N/X/X/T, index inclusion means funds tied to $10T+ in AUM have to hold positions, yet we’re still talking about a company with only ~$164M market cap, $65.8M YTD revenue and a P/S near 2.5x, so I’m getting structural institutional demand on top of a high growth microgrid story at a discount

0 · Reply

MrEsKurr Nov. 26 at 6:08 AM

$NEPH if upside persist tommorow im in this baby.

0 · Reply

Oh_My_Lanta Nov. 26 at 12:46 AM

$NEPH always crazy moves

0 · Reply

stockmet Nov. 25 at 7:56 PM

$NEPH heating up 🔥

0 · Reply

Unalloyed Nov. 17 at 7:39 PM

$NEPH https://www.sec.gov/Archives/edgar/data/1196298/000149315224018645/forms-3.htm

1 · Reply

Unalloyed Nov. 17 at 7:37 PM

$NEPH

0 · Reply

Stock_Catcher Nov. 17 at 7:33 PM

$NEPH 👀.

0 · Reply

topstockalerts Nov. 17 at 7:03 PM

$NEPH not a bad place for a swing idea 💡

0 · Reply

d_risk Nov. 7 at 12:03 AM

$NEPH - NEPHROS INC - 10Q - Updated Risk Factors NEPH flags new risk: heavy reliance on third-party contractors for water filtration product installation and service could hurt business and reputation if quality or compliance falters. #WaterFiltration #ContractorDependence #ComplianceRisk #QualityControl #Third-PartyRisk 🟢 Added 🟠 Removed https://d-risk.ai/NEPH/10-Q/2025-11-06

1 · Reply

Logan12071 Nov. 6 at 9:12 PM

$NEPH that’s a good PR

0 · Reply

Nephros, Inc. (NEPH) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 4:00 PM EDT - 5 weeks ago

Nephros Schedules Third Quarter 2025 Financial Results Conference Call

Aug 8, 2025, 9:03 AM EDT - 4 months ago

Nephros, Inc. (NEPH) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:00 PM EDT - 4 months ago

Nephros Announces Strong Second Quarter Financial Results

Jul 31, 2025, 4:00 PM EDT - 4 months ago

Nephros Schedules Second Quarter 2025 Financial Results Conference Call

Dec 4, 2024, 9:00 AM EST - 1 year ago

Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC

Nov 9, 2024, 1:37 PM EST - 1 year ago

Nephros, Inc. (NEPH) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 7:30 AM EDT - 1 year ago

Nephros Schedules Third Quarter 2024 Financial Results Conference Call

Oct 17, 2024, 9:00 AM EDT - 1 year ago

Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton

Aug 10, 2024, 1:58 PM EDT - 1 year ago

Nephros, Inc. (NEPH) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:01 PM EDT - 1 year ago

Nephros Announces Financial Results for Quarter Ended June 30, 2024

Aug 1, 2024, 7:30 AM EDT - 1 year ago

Nephros Schedules Second Quarter 2024 Financial Results Conference Call

Mar 7, 2024, 7:51 PM EST - 1 year ago

Nephros, Inc. (NEPH) Q4 2023 Earnings Call Transcript

Mar 7, 2024, 4:15 PM EST - 1 year ago

Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results

Feb 29, 2024, 4:30 PM EST - 1 year ago

Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results

Nov 10, 2023, 5:26 AM EST - 2 years ago

Nephros, Inc. (NEPH) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:15 PM EST - 2 years ago

Nephros Announces Results for Quarter Ended September 30, 2023

Nov 1, 2023, 7:30 AM EDT - 2 years ago

Nephros Hires Judy Krandel as Chief Financial Officer

Oct 25, 2023, 7:30 AM EDT - 2 years ago

Nephros Schedules Third Quarter 2023 Financial Results Conference Call

Sep 19, 2023, 4:30 PM EDT - 2 years ago

Nephros to Present at LD Micro Main Event XVI

Aug 9, 2023, 8:13 PM EDT - 2 years ago

Nephros, Inc. (NEPH) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 4:15 PM EDT - 2 years ago

Nephros Announces Results for Quarter Ended June 30, 2023

Jul 26, 2023, 7:30 AM EDT - 2 years ago

Nephros Schedules Second Quarter 2023 Financial Results Conference Call

May 24, 2023, 7:30 AM EDT - 2 years ago

Nephros to Present at LD Micro Invitational XIII

May 10, 2023, 4:15 PM EDT - 2 years ago

Nephros Announces Results for Quarter Ended March 31, 2023

May 8, 2023, 7:30 AM EDT - 2 years ago

Nephros Announces CEO Retirement and Succession Plan

Apr 26, 2023, 7:30 AM EDT - 2 years ago

Nephros Schedules First Quarter 2023 Financial Results Conference Call

Apr 4, 2023, 7:30 AM EDT - 2 years ago

Nephros Announces Preliminary Results for First Quarter 2023

Mar 8, 2023, 10:28 PM EST - 2 years ago

Nephros, Inc. (NEPH) Q4 2022 Earnings Call Transcript

Mar 8, 2023, 4:15 PM EST - 2 years ago

Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results

Mar 1, 2023, 4:30 PM EST - 3 years ago

Nephros and Donastar Announce Strategic Partnership

Feb 22, 2023, 4:30 PM EST - 3 years ago

Nephros Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call

Jan 11, 2023, 7:30 AM EST - 3 years ago

Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022

Nov 6, 2022, 2:29 AM EST - 3 years ago

Nephros, Inc. (NEPH) Q3 2022 Earnings Call Transcript

Nov 2, 2022, 4:15 PM EDT - 3 years ago

Nephros Announces Results for Quarter Ended September 30, 2022

Oct 19, 2022, 7:30 AM EDT - 3 years ago

Nephros Third Quarter 2022 Financial Results Conference Call

Oct 12, 2022, 7:30 AM EDT - 3 years ago

Nephros to Present at LD Micro Main Event XV

Oct 11, 2022, 7:30 AM EDT - 3 years ago

Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Preliminary Results for Quarter Ended September 30, 2022

Sep 28, 2022, 7:30 AM EDT - 3 years ago

Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation

Sep 8, 2022, 4:00 PM EDT - 3 years ago

Nephros Appoints Joe Harris to Its Board of Directors

Aug 10, 2022, 9:32 PM EDT - 3 years ago

Nephros, Inc.'s (NEPH) CEO Andy Astor on Q2 2022 Results - Earnings Call Transcript

Aug 10, 2022, 4:15 PM EDT - 3 years ago

Nephros Announces Results for Quarter Ended June 30, 2022

Jul 27, 2022, 7:30 AM EDT - 3 years ago

Nephros Second Quarter 2022 Financial Results Conference Call

Jul 6, 2022, 7:30 AM EDT - 3 years ago

Nephros Announces Preliminary Results for Quarter Ended June 30, 2022 and Projects Positive Net Cash Flow in 12 Months

May 17, 2022, 7:30 AM EDT - 3 years ago

Nephros Receives FDA 510(k) Clearance for HDF Assist Module

May 7, 2022, 9:16 AM EDT - 3 years ago

Nephros, Inc. (NEPH) CEO Andy Astor on Q1 2022 Results - Earnings Call Transcript

May 4, 2022, 4:15 PM EDT - 3 years ago

Nephros Announces Results for Quarter Ended March 31, 2022

Apr 27, 2022, 7:30 AM EDT - 3 years ago

Nephros First Quarter 2022 Financial Results Conference Call

Apr 26, 2022, 7:30 AM EDT - 3 years ago

Nephros Unveils New Branding and Website

Mar 21, 2022, 7:30 AM EDT - 4 years ago

Nephros to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

MatthLewis Dec. 1 at 6:50 PM

0 · Reply

MrEsKurr Nov. 26 at 6:08 AM

$NEPH if upside persist tommorow im in this baby.

0 · Reply

Oh_My_Lanta Nov. 26 at 12:46 AM

$NEPH always crazy moves

0 · Reply

stockmet Nov. 25 at 7:56 PM

$NEPH heating up 🔥

0 · Reply

Unalloyed Nov. 17 at 7:39 PM

$NEPH https://www.sec.gov/Archives/edgar/data/1196298/000149315224018645/forms-3.htm

1 · Reply

Unalloyed Nov. 17 at 7:37 PM

$NEPH

0 · Reply

Stock_Catcher Nov. 17 at 7:33 PM

$NEPH 👀.

0 · Reply

topstockalerts Nov. 17 at 7:03 PM

$NEPH not a bad place for a swing idea 💡

0 · Reply

d_risk Nov. 7 at 12:03 AM

1 · Reply

Logan12071 Nov. 6 at 9:12 PM

$NEPH that’s a good PR

0 · Reply

Doozio Oct. 28 at 3:44 PM

$NEPH lets bang bro. 🐒🍌🧠⏰♾️

1 · Reply

Dilutable Oct. 25 at 9:37 AM

$SOTK Poised for growth, to reach triple-digit market cap I believe. Love these small companies that swung profitable and execute on plan. Just like $ESP $OPXS $NEPH

1 · Reply

Dilutable Oct. 24 at 5:53 PM

$NEPH IMHO this will hit a triple digit market cap. Solid small company poised for slow, but steady growth.

0 · Reply

bullrun10 Oct. 16 at 8:57 AM

$NEPH Double #insidebar Getting ready for another move up. $6+ incoming. #StocksToWatch

0 · Reply

suoerlopez Oct. 6 at 2:01 PM

$NEPH someone is buying like there is no tomorrow. This should be 9 to 20 bucks

0 · Reply

suoerlopez Oct. 6 at 2:00 PM

$NEPH what is going on??

0 · Reply

OptionTone Oct. 5 at 1:31 PM

$NEPH Healthcare technology. Testing key support. Volume pattern shows distribution. Growth concerns persisting.

0 · Reply

Doozio Sep. 13 at 9:34 PM

$NEPH is now 🐒🍌🧠⏰♾️

1 · Reply

GluttonBoy Sep. 9 at 5:07 PM

TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play Watching. $NEPH $BURU $JZXN $GREE $RYDE

0 · Reply

NVDAMillionaire Sep. 4 at 7:48 AM

$NEPH Great piece that accurately captures NEPH's current position. So if you want to refresh your understanding of NEPH or learn about NEPH for the first time, this is essential reading. https://beyondspx.com/quote/NEPH/nephros-nasdaq-neph-ultrafiltration-s-ascent-to-sustained-profitability-and-market-expansion#analysis

1 · Reply

DARKP00L Sep. 3 at 6:50 PM

$NEPH this stock is attracting a lot of interest. Be prepared for possible changes!

0 · Reply

Market Cap	56.43M
Revenue (ttm)	14.16M
Net Income (ttm)	70,000.00
EPS (ttm)	N/A
PE Ratio	40.85
Forward PE	N/A
Profit Margin	0.49%
Debt to Equity Ratio	0.00

Volume	70,600
Avg Vol	75,664
Day's Range	N/A - N/A
Shares Out	10.63M
Stochastic %K	67%
Beta	1.48
Analysts	Strong Sell
Price Target	$6.50